Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits

Citation
M. Gardinali et al., Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits, AM J R CRIT, 161(3), 2000, pp. 1022-1029
Citations number
53
Categorie Soggetti
Cardiovascular & Respiratory Systems","da verificare
Journal title
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
ISSN journal
1073449X → ACNP
Volume
161
Issue
3
Year of publication
2000
Pages
1022 - 1029
Database
ISI
SICI code
1073-449X(200003)161:3<1022:IOCCPA>2.0.ZU;2-S
Abstract
Acute lung injury is frequent after severe peritonitis. The aim of this stu dy was to investigate whether inhibition of the adhesion molecule CD11-CD18 on polymorphonuclear leukocytes (PMNs) would have any beneficial effects o n pulmonary function and mortality in an animal model reproducing these cli nical conditions. Acute peritonitis was induced in 36 rabbits by intraperit oneal injection of zymosan (0.6 g/kg) suspended in mineral oil; 20 were pre treated with a murine-specific IgG2a anti-CD18 monoclonal antibody, 46 (con trols) with nonspecific purified murine Ige (1 mg/kg), The animals were fol lowed for 10 d, then killed for histologic examination of the lungs, blood samples were taken on Days 0, 1, 3, 7 and 10 for red blood cell (RBC), whit e blood cell (WBC), and platelet counts, pH, Po-2, Pco(2), carbon dioxide c ontent (HCO3-) measurements, and renal and liver tests. Treatment with the anti-CD18 monoclonal antibody reduced mortality by approximately 40% (p < 0 .05). Po-2 was higher in these treated animals than in the control animals throughout the study (p < 0.05 on Day 1, 3, and 10). On Day 1 control anima ls had significant leukopenia, whereas anti-CD18-treated animals had a mode rate increase of the number of circulating WBC compared with baseline value s (p < 0.05 between groups). The lungs of the anti-CD18-treated animals sho wed minor signs of inflammation and PMN infiltration whereas controls had i nterstitial and intra-alveolar edema and a large number of granulocytes. Qu antification of PMNs by morphometry showed that there were constantly less granulocytes in the lungs of the animals treated with the antl-CD18 antibod y (p< 0.001), PMN infiltration correlated with the levels of Po-2 (p < 0.00 1). Lung tissue of anti-CD18-treated rabbits contained less malonyldialdehy de, a by-product of membrane lipid peroxidation by PMN oxygen radicals (950 +/- 120 versus 1,710 +/- 450 pM/mg of protein) and, conversely, more of th e antioxidant cr-tocopherol (136 +/- 22 versus 40 +/- 9 ng/mg of protein), than the control rabbits (p < 0.01). In this particular model of ARDS the m onoclonal antibody against the CD11-CD18 complex had a beneficial effect, r educing PMN infiltration and oxygen radical release in the lungs, preventin g alveolocapillary membrane damage, improving gas exchange and, finally, si gnificantly reducing mortality.